MGRX — Mangoceuticals, Inc. Common Stock · rev $456.0K

Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.

Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.

Use this MGRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MGRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MGRX SEC filings page. Lician reads the product cache first so this HTML stays unique to Mangoceuticals, Inc. Common Stock even when a live quote feed is slow.